Extrawell Pharmaceutical Holdings Limited
HKEX:0858.HK
Overview | Financials
Company Name | Extrawell Pharmaceutical Holdings Limited |
Symbol | 0858.HK |
Currency | HKD |
Price | 0.032 |
Market Cap | 76,480,000 |
Dividend Yield | 0% |
52-week-range | 0.026 - 0.054 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Dr. Yi Xie Ph.D. |
Website | https://www.extrawell.com.hk |
An error occurred while fetching data.
About Extrawell Pharmaceutical Holdings Limited
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD